Some cancer outcomes
ASCO Genitourinary Cancers Symposium: Cabozantinib improves on standard of care for advanced kidney cancer
Aspirin may reduce risk of dying from prostate cancer
Insight on molecular genetics of testicular cancer
Outcomes from ASCO Genitourinary Cancers Symposium